Latest news with #MSCIGlobalStandardIndexes
Yahoo
14-05-2025
- Business
- Yahoo
MSCI changes Burford Capital country classification to USA from United Kingdom
NEW YORK, May 14, 2025 /PRNewswire/ -- Burford Capital Limited ("Burford" or the "Company"), the leading global finance and asset management firm focused on law, notes the announcement by MSCI for the purpose of its MSCI Global Standard Indexes of a change to the country classification of Burford Capital. Implemented as of the close on May 30, 2025, and effective June 2, 2025, Burford will be added to the MSCI USA Indexes and MSCI US Equity Standard and Small Cap Indexes and deleted from the MSCI United Kingdom Indexes. The change of Burford's country classification is expected to result in some rotation of passive holdings from the Company's London stock line to the New York stock line in the immediate term. About Burford Capital Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the New York Stock Exchange (NYSE: BUR) and the London Stock Exchange (LSE: BUR) and works with companies and law firms around the world from its global network of offices. For more information, please visit This press release does not constitute an offer to sell or the solicitation of an offer to buy any ordinary shares or other securities of Burford. This press release does not constitute an offer of any Burford private fund. Burford Capital Investment Management LLC, which acts as the fund manager of all Burford private funds, is registered as an investment adviser with the US Securities and Exchange Commission. The information provided in this press release is for informational purposes only. Past performance is not indicative of future results. The information contained in this press release is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including interests or shares in any of Burford private funds). Any such offer or solicitation may be made only by means of a final confidential private placement memorandum and other offering documents. Forward-looking statements This press release contains "forward-looking statements" within the meaning of Section 27A of the US Securities Act of 1933, as amended, and Section 21E of the US Securities Exchange Act of 1934, as amended, that are intended to be covered by the safe harbor provided for under these sections. In some cases, words such as "aim", "anticipate", "believe", "continue", "could", "estimate", "expect", "forecast", "guidance", "intend", "may", "plan", "potential", "predict", "projected", "should" or "will", or the negative of such terms or other comparable terminology, are intended to identify forward-looking statements. Although Buford believes that the assumptions, expectations, projections, intentions and beliefs about future results and events reflected in forward-looking statements have a reasonable basis and are expressed in good faith, forward-looking statements involve known and unknown risks, uncertainties and other factors, which could cause Burford's actual results and events to differ materially from (and be more negative than) future results and events expressed, projected or implied by these forward-looking statements. Factors that might cause future results and events to differ include, among others, those discussed in the "Risk Factors" section of Burford's Annual Report on Form 10-K for the year ended December 31, 2024 filed with the US Securities and Exchange Commission on March 3, 2025. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements contained in the periodic and current reports that Burford files with or furnishes to the US Securities and Exchange Commission. Many of these factors are beyond Burford's ability to control or predict, and new factors emerge from time to time. Furthermore, Burford cannot assess the impact of each such factor on its business or the extent to which any factor or combination of factors may cause actual results and events to be materially different from those contained in any forward-looking statement. Given these uncertainties, readers are cautioned not to place undue reliance on Burford's forward-looking statements. All subsequent written and oral forward-looking statements attributable to Burford or to persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. The forward-looking statements speak only as of the date of this press release and, except as required by applicable law, Burford undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. View original content: SOURCE Burford Capital Sign in to access your portfolio
Time of India
14-05-2025
- Business
- Time of India
Nykaa, Coromandel International to join MSCI India Index in May review
NEW DELHI: Beauty and fashion retailer Nykaa and fertilizer maker Coromandel International are set to be included in the MSCI India Index , according to the latest review by global index provider MSCI. The changes to the MSCI Global Standard Indexes will take effect from May 30, 2025, as stated in MSCI's announcement. FSN E-Commerce Ventures ' shares registered a 3.44% increase on the BSE. Coromandel International's stock rose by 1.82% but later gave up all gains to end nearly 4% lower. MSCI, serves as a primary provider of essential decision support instruments and services for international investors. It has announced that in the MSCI Global Smallcap Indexes, 11 firms will be added, while 22 companies will move out effective May 30. The new additions comprise AWL Agri Business, ACME Solar Holdings, Authum Investment, Dr Agarwals Health Care, Godrej Agrovet, Hexaware Technologies, International Gemmological, Le Travenues Technology, Sagility India, Sai Life Sciences and Tata Technologies. The companies set for removal include Aarti Drugs, Allcargo Logistics, Coromandel International, E2E Networks, Electronics Mart India, Gateway Distriparks, Godrej Industries, Greenpanel Industries, Gujarat Alkalies, HeidelbergCement, Hemisphere Properties, Moschip Technologies, NOCIL, Orchid Pharma, Orissa Minerals Development Company, Paisalo Digital, Patel Engineering, Prince Pipes and Fittings, Rossari Biotech, Share India Securities, Shyam Metalics and TeamLease Services. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
Time of India
14-05-2025
- Business
- Time of India
Nykaa, Coromandel International to be added to MSCI India Index in May review
FSN E-Commerce Ventures Ltd, which owns fashion and beauty retailer Nykaa , and fertilizers company Coromandel International will be added to the MSCI India Index , as per a latest review by global index compiler MSCI. The changes in the constituents for the MSCI Global Standard Indexes will take place from May 30, 2025, according to an announcement by MSCI. MSCI is a leading provider of critical decision support tools and services for the global investment community. Shares of FSN E-Commerce Ventures climbed 3.44 per cent on the BSE. Play Video Pause Skip Backward Skip Forward Unmute Current Time 0:00 / Duration 0:00 Loaded : 0% 0:00 Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 1x Playback Rate Chapters Chapters Descriptions descriptions off , selected Captions captions settings , opens captions settings dialog captions off , selected Audio Track default , selected Picture-in-Picture Fullscreen This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Text Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Transparent Caption Area Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Drop shadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Don't Bother With An Expensive Will (Do This Instead) Local Will Finder Undo The stock of Coromandel International went up by 1.82 per cent before paring all gains to drop nearly 4 per cent. In the MSCI Global Smallcap Indexes, 11 firms will be added, while 22 companies will move out effective May 30. Live Events The additions are AWL Agri Business, ACME Solar Holdings, Authum Investment, Dr Agarwals Health Care, Godrej Agrovet, Hexaware Technologies, International Gemmological, Le Travenues Technology, Sagility India, Sai Life Sciences and Tata Technologies. However, Aarti Drugs, Allcargo Logistics, Coromandel International, E2E Networks, Electronics Mart India, Gateway Distriparks, Godrej Industries, Greenpanel Industries, Gujarat Alkalies, HeidelbergCement, Hemisphere Properties, Moschip Technologies, NOCIL, Orchid Pharma, Orissa Minerals Development Company, Paisalo Digital, Patel Engineering, Prince Pipes and Fittings, Rossari Biotech, Share India Securities, Shyam Metalics and TeamLease Services will move out.
Business Wire
13-05-2025
- Business
- Business Wire
MSCI Equity Indexes May 2025 Index Review
LONDON--(BUSINESS WIRE)--MSCI Inc. (NYSE: MSCI), a leading provider of critical decision support tools and services for the global investment community, announced the results of the May 2025 Index Review for the MSCI Equity Indexes. All changes will be implemented as of the close of May 30, 2025. Highlights include: MSCI Global Standard Indexes: Thirty securities will be added to and 61 securities will be deleted from the MSCI ACWI Index. The three largest additions to the MSCI World Index measured by full company market capitalization will be Ryanair Holdings (Ireland), Sigma Healthcare (Australia) and International Airlines Group (Spain). The three largest additions to the MSCI Emerging Markets Index measured by full company market capitalization will be ADNOC Gas (United Arab Emirates), Dubai Electricity & Water Authority (United Arab Emirates) and Sichuan Biokin Pharmaceutical A (HK-C) (China). MSCI Global Small Cap Indexes: There will be 147 additions to and 201 deletions from the MSCI ACWI Small Cap Index. MSCI Global Investable Market Indexes: There will be 123 additions to and 208 deletions from the MSCI ACWI Investable Market Index (IMI). MSCI Global All Cap Indexes: There will be 98 additions to and 108 deletions from the MSCI World All Cap Index. MSCI Frontier Markets Indexes: There will be twelve additions to and three deletions from the MSCI Frontier Markets Index. The three largest additions to the MSCI Frontier Markets Index measured by full company market capitalization will be Tien Phong Commercial (Vietnam), Credit Du Maroc (Morocco) and Sonasid (Morocco). There will be 16 additions to and eight deletions from the MSCI Frontier Markets Small Cap Index. In light of currently observed market accessibility issues, MSCI will continue to not implement changes as part of this Index Review for any securities classified in Bangladesh for the MSCI Bangladesh Indexes or impacted composite indexes. These changes, along with other changes across MSCI Equity Indexes including the MSCI US Equity Indexes, MSCI US REIT Index, MSCI China A Onshore Indexes and China All Shares Indexes are available on MSCI's "Index Review" web page: -Ends- About MSCI MSCI is a leading provider of critical decision support tools and services for the global investment community. With over 50 years of expertise in research, data and technology, we power better investment decisions by enabling clients to understand and analyze key drivers of risk and return and confidently build more effective portfolios. We create industry-leading research-enhanced solutions that clients use to gain insight into and improve transparency across the investment process. To learn more, please visit This document and all of the information contained in it, including without limitation all text, data, graphs, charts (collectively, the 'Information') is the property of MSCI Inc. or its subsidiaries (collectively, 'MSCI'), or MSCI's licensors, direct or indirect suppliers or any third party involved in making or compiling any Information (collectively, with MSCI, the 'Information Providers') and is provided for informational purposes only. The Information may not be modified, reverse-engineered, reproduced or redisseminated in whole or in part without prior written permission from MSCI. All rights in the Information are reserved by MSCI and/or its Information Providers. The Information may not be used to create derivative works or to verify or correct other data or information. For example (but without limitation), the Information may not be used to create indexes, databases, risk models, analytics, software, or in connection with the issuing, offering, sponsoring, managing or marketing of any securities, portfolios, financial products or other investment vehicles utilizing or based on, linked to, tracking or otherwise derived from the Information or any other MSCI data, information, products or services. The user of the Information assumes the entire risk of any use it may make or permit to be made of the Information. NONE OF THE INFORMATION PROVIDERS MAKES ANY EXPRESS OR IMPLIED WARRANTIES OR REPRESENTATIONS WITH RESPECT TO THE INFORMATION (OR THE RESULTS TO BE OBTAINED BY THE USE THEREOF), AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, EACH INFORMATION PROVIDER EXPRESSLY DISCLAIMS ALL IMPLIED WARRANTIES (INCLUDING, WITHOUT LIMITATION, ANY IMPLIED WARRANTIES OF ORIGINALITY, ACCURACY, TIMELINESS, NON-INFRINGEMENT, COMPLETENESS, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE) WITH RESPECT TO ANY OF THE INFORMATION. Without limiting any of the foregoing and to the maximum extent permitted by applicable law, in no event shall any Information Provider have any liability regarding any of the Information for any direct, indirect, special, punitive, consequential (including lost profits) or any other damages even if notified of the possibility of such damages. The foregoing shall not exclude or limit any liability that may not by applicable law be excluded or limited, including without limitation (as applicable), any liability for death or personal injury to the extent that such injury results from the negligence or willful default of itself, its servants, agents or sub-contractors. Information containing any historical information, data or analysis should not be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. Past performance does not guarantee future results. The Information may include 'Signals,' defined as quantitative attributes or the product of methods or formulas that describe or are derived from calculations using historical data. Neither these Signals nor any description of historical data are intended to provide investment advice or a recommendation to make (or refrain from making) any investment decision or asset allocation and should not be relied upon as such. Signals are inherently backward-looking because of their use of historical data, and they are not intended to predict the future. The relevance, correlations and accuracy of Signals frequently will change materially. The Information should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. All Information is impersonal and not tailored to the needs of any person, entity or group of persons. None of the Information constitutes an offer to sell (or a solicitation of an offer to buy), any security, financial product or other investment vehicle or any trading strategy. It is not possible to invest directly in an index. Exposure to an asset class or trading strategy or other category represented by an index is only available through third party investable instruments (if any) based on that index. MSCI does not issue, sponsor, endorse, market, offer, review or otherwise express any opinion regarding any fund, ETF, derivative or other security, investment, financial product or trading strategy that is based on, linked to or seeks to provide an investment return related to the performance of any MSCI index (collectively, 'Index Linked Investments'). MSCI makes no assurance that any Index Linked Investments will accurately track index performance or provide positive investment returns. MSCI Inc. is not an investment adviser or fiduciary and MSCI makes no representation regarding the advisability of investing in any Index Linked Investments. Index returns do not represent the results of actual trading of investible assets/securities. MSCI maintains and calculates indexes, but does not manage actual assets. The calculation of indexes and index returns may deviate from the stated methodology. Index returns do not reflect payment of any sales charges or fees an investor may pay to purchase the securities underlying the index or Index Linked Investments. The imposition of these fees and charges would cause the performance of an Index Linked Investment to be different than the MSCI index performance. The Information may contain back tested data. Back-tested performance is not actual performance, but is hypothetical. There are frequently material differences between back tested performance results and actual results subsequently achieved by any investment strategy. Constituents of MSCI equity indexes are listed companies, which are included in or excluded from the indexes according to the application of the relevant index methodologies. Accordingly, constituents in MSCI equity indexes may include MSCI Inc., clients of MSCI or suppliers to MSCI. Inclusion of a security within an MSCI index is not a recommendation by MSCI to buy, sell, or hold such security, nor is it considered to be investment advice. Data and information produced by various affiliates of MSCI Inc., including MSCI ESG Research LLC and Barra LLC, may be used in calculating certain MSCI indexes. More information can be found in the relevant index methodologies on MSCI receives compensation in connection with licensing its indexes to third parties. MSCI Inc.'s revenue includes fees based on assets in Index Linked Investments. Information can be found in MSCI Inc.'s company filings on the Investor Relations section of MSCI ESG Research LLC is a Registered Investment Adviser under the Investment Advisers Act of 1940 and a subsidiary of MSCI Inc. Neither MSCI nor any of its products or services recommends, endorses, approves or otherwise expresses any opinion regarding any issuer, securities, financial products or instruments or trading strategies and MSCI's products or services are not a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such, provided that applicable products or services from MSCI ESG Research may constitute investment advice. MSCI ESG Research materials, including materials utilized in any MSCI ESG Indexes or other products, have not been submitted to, nor received approval from, the United States Securities and Exchange Commission or any other regulatory body. MSCI ESG and climate ratings, research and data are produced by MSCI ESG Research LLC, a subsidiary of MSCI Inc. MSCI ESG Indexes, Analytics and Real Estate are products of MSCI Inc. that utilize information from MSCI ESG Research LLC. MSCI Indexes are administered by MSCI Limited (UK) and MSCI Deutschland GmbH. Please note that the issuers mentioned in MSCI ESG Research materials sometimes have commercial relationships with MSCI ESG Research and/or MSCI Inc. (collectively, 'MSCI') and that these relationships create potential conflicts of interest. In some cases, the issuers or their affiliates purchase research or other products or services from one or more MSCI affiliates. In other cases, MSCI ESG Research rates financial products such as mutual funds or ETFs that are managed by MSCI's clients or their affiliates, or are based on MSCI Inc. Indexes. In addition, constituents in MSCI Inc. equity indexes include companies that subscribe to MSCI products or services. In some cases, MSCI clients pay fees based in whole or part on the assets they manage. MSCI ESG Research has taken a number of steps to mitigate potential conflicts of interest and safeguard the integrity and independence of its research and ratings. More information about these conflict mitigation measures is available in our Form ADV, available at Any use of or access to products, services or information of MSCI requires a license from MSCI. MSCI, Barra, RiskMetrics, IPD and other MSCI brands and product names are the trademarks, service marks, or registered trademarks of MSCI or its subsidiaries in the United States and other jurisdictions. The Global Industry Classification Standard (GICS) was developed by and is the exclusive property of MSCI and S&P Dow Jones Indices. 'Global Industry Classification Standard (GICS)' is a service mark of MSCI and S&P Dow Jones Indices. MIFID2/MIFIR notice: MSCI ESG Research LLC does not distribute or act as an intermediary for financial instruments or structured deposits, nor does it deal on its own account, provide execution services for others or manage client accounts. No MSCI ESG Research product or service supports, promotes or is intended to support or promote any such activity. MSCI ESG Research is an independent provider of ESG data.
Express Tribune
02-03-2025
- Business
- Express Tribune
Pakistan's stocks: index showing signs of exhaustion
As per the latest MSCI decision, Pakistan's weight in MSCI Global Standard Indexes has improved to 0.023% compared to 0.016% earlier. PHOTO: FILE Listen to article Pakistan Stock Exchange's (PSX) benchmark KSE-100 index experienced an extraordinary surge in 2024, recording an 85% increase in Pakistani rupee (PKR) terms and an 87% rise in US dollar (USD) terms. This remarkable performance was driven by a combination of favourable macroeconomic factors, including declining inflation, a stable currency and aggressive monetary easing by the State Bank of Pakistan (SBP). However, as we progress into 2025, the KSE-100 index appears to be showing signs of exhaustion, with the market becoming range bound for the last three months and lacking clear directional momentum. To understand the current dynamics of the market and what lies ahead, it is essential to analyse the performance and contributions of various key sectors. In 2024, the banking sector remained a cornerstone of the KSE-100 index, contributing significantly to its upward trajectory. Although the sector's earnings remained flat on a year-on-year basis at Rs156 billion, it accounted for 39% of the total index profitability in the first quarter of fiscal year 2024-25 (1QFY25). Despite a decline in interest rates, banks maintained robust earnings, supported by improved asset quality and increased lending activities. The oil and gas exploration sector faced challenges in 2024, with profitability declining 21% year-on-year in 1QFY25. This downturn was primarily due to fluctuating global oil prices and operational challenges. With focus on reduction in circular debt under the IMF umbrella, the cash flow for this sector should improve going forward. Oil and gas marketing companies experienced an 86% year-on-year decline in profitability during 1QFY25. The significant drop was due to inventory losses stemming from volatile oil prices and regulatory challenges affecting pricing mechanisms. The cement industry experienced a 14% year-on-year increase in earnings, amounting to Rs35 billion in 1QFY25. This growth was driven by higher retention prices and a reduction in coal costs, despite a decrease in local demand. Market leaders in both North and South regions of the country have benefited from these favourable conditions, contributing positively to the index. The government's recent incentive to stimulate the real estate sector should provide impetus for further growth. The fertiliser sector saw a 16% year-on-year increase in profitability, reaching Rs56 billion in 1QFY25. This was largely due to higher urea and di-ammonium phosphate (DAP) prices, which offset the decline in sales volume. The evergreen dividend players in the sector will be favoured to generate the yield in the falling interest rate environment. The food and personal care sector faced a 15% year-on-year decline in earnings in 1QFY25. The decrease can be attributed to rising input costs and competitive market conditions, which squeezed profit margins for many companies. Also, the erosion in the earnings of middle and lower class will impact the profitability in this sector. The pharmaceutical industry emerged as a top performer in 2024, with its market capitalisation increasing 198%. This surge was driven by improved financial results following a decline in raw material prices, currency stabilisation, lower inflation and the deregulation of non-essential drugs. Companies like GlaxoSmithKline Pakistan saw their market capitalisation rise 385%, reporting a profit of Rs3.6 billion in the first nine months of 2024, compared to a loss of Rs392 million in the same period in 2023. The textile sector faced headwinds, with profitability declining 60% year-on-year in 1QFY25. Challenges included rising production costs, energy shortages and increased competition in international markets, which collectively impacted the sector's performance. The technology sector does not have major weightage in the index currently but it is gaining momentum with the listing of new companies. The sector reported a loss of Rs1.4 billion in 1QFY25, primarily led by losses of Pakistan Telecommunication Company Limited (PTCL). Despite the overall sectoral loss, individual companies like Air Link Communication experienced significant gains, with a 268% increase in share price in 2024 due to improved mobile sales and the anticipated launch of locally assembled TVs and laptops. The exceptional performance of the KSE-100 index so far can be attributed to several macroeconomic and sector-specific factors. The State Bank implemented aggressive monetary easing, reducing the policy rate by 900 basis points, which lowered borrowing costs and stimulated economic activity. Despite a constant political overhang, a decline in inflation, IMF programme and stable Pakistani rupee enhanced investor confidence, attracting both local and foreign investment. However, all these news have already been incorporated into the recent index performance and it seems that investors are clearly looking for new triggers for the next leg of outperformance. The writer is a financial market enthusiast and is attached to Pakistan's stocks, commodities and emerging technology
